H.Res. 161 · 113th Congress

Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs.

Stage
In committee
Sponsor
Hal Rogers
Introduced
2013-04-15
Latest action
2013-04-19 · Referred to the Subcommittee on Health.

Action history

  1. 2013-04-19Referred to the Subcommittee on Health.
  2. 2013-04-15Introduced in House
  3. 2013-04-15Referred to the House Committee on Energy and Commerce.